Frost & Sullivan to Host Complimentary Web Conference: Will the U.S. Implantable Defibrillator Market Recover?

Informations

• Publié par: frost-sullivan
• Nombre de lectures: 5
• Langue: English

Extrait

Frost & Sullivan to Host Complimentary Web

Conference: Will the U.S. Implantable

Defibrillator Market Recover?

PR Newswire

LONDON, June 6, 2012

- Comparison of the ICD Market in the U.S. and Western Europe

LONDON

,

June 6, 2012

/PRNewswire/ --

Western Europe

and

the United States

are the biggest markets for Implantable Cardioverter Defibrillator. The

Implantable Cardioverter Defibrillator is one of the most challenging and

dynamic markets in

the United States

. 2011 witnessed one of the major dips in

the unit sales of ICD in the U.S. Together with the decreasing pricing trends, the

market for ICD in the U.S. decreased to new levels. This web conference will

cover the key reasons for the dropdown of ICD unit sales in the U.S. and also a

comparative analysis with some trends in the ICD market in Western European

countries.

Frost & Sullivan

will host a complimentary web conference entitled "

Will the

U.S. Implantable Defibrillator Market Recover,

" which will take place on

Wednesday

13th June 2012

at

2.00 pm BST

. Research Analyst Brahadeesh

Chandrasekaran has completed extensive analysis on the Implantable

Cardioverter Defibrillator market. The research expert will lead a short

teleconference about new findings that affect the market, followed by a live

question-and-answer session. Highlights of the web conference will include

heart failure, implantable cardioverter defibrillator, implantation, cardiac

devices and cardiac rhythm management.

To participate in this complimentary web conference, please email Janique

Morvan, Corporate Communications at [e-mail], with your

full contact details. Upon receipt of the above-mentioned information, a

registration link will be emailed to you.

This web conference will benefit the cardiac rhythm management industry and

manufacturers by discussing the various reasons for the market decline in 2011

and the response from physicians, electrophysiologists for implantation and

guidelines.

"The publication of non-evidence based ICD implantation has triggered down

the market for ICD in the U.S. The results from this study have been highly

influential and has raised the questions on guidelines being followed by the

medical professionals," observes Brahadeesh Chandrasekaran. "The study in

the United States

has created the curiosity at a Western European level, the

second biggest market ICDs in the world."

To receive a link of the recorded web conference and / or further information

on this research, please email Janique Morvan at [e-mail]

with your full contact details.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with

clients to leverage visionary innovation that addresses the global challenges

and related growth opportunities that will make or break today's market